Key points
In week 37, circulation of SARS-CoV-2 accelerated throughout metropolitan France, with a sharp rise in virological indicators.
- Metropolitan France:
- Significant rise in incidence across the territory
- Increases in incidence rate most substantial in the under-20 and 30-49 age groups (more than 50%)
- Stabilisation of hospital indicators at national level with regional disparities
- Overseas France:
- Incidence rate falling in most regions except Martinique
Variants
Omicron sub-lineages: BA.5 omnipresent, accounting for 93% of sequences in the week 36 Flash Survey (5 September)
Prevention
- Vaccination on 19 September 2022 (Vaccin Covid data):
- 74.3% of the population aged 18+ and 82.4% of people aged 65+ had received a booster dose
- 28.7% of 60-79 year-olds (representing 34.2% of those eligible given the date of their last injection) and 36.4% of people aged 80+ (47.8% of those eligible) had received a second booster dose
- Given the acceleration in circulation of SARS-CoV-2, compliance with the combined measures remains necessary:
- staying up-to-date with COVID-19 vaccinations, including the second booster dose for vulnerable people;
- self-isolation in case of a positive test for COVID-19 and/or symptoms;
- continued application of precautionary measures, including wearing a mask, particularly around people atrisk and in enclosed areas favourable to transmission (especially public transport and large gatherings), as well as frequent hand washing and ventilation of enclosed spaces.
